Soluble FLT-1 rules placental destiny

Area of Science:

• Reproductive Biology
• Obstetrics and Gynecology
• Developmental Biology

Background:

• Placenta previa, where the placenta covers the internal uterine os, poses risks of severe hemorrhage to mother and fetus.
• The phenomenon of placental "migration" allows some women to recover from placenta previa, but its underlying mechanisms remain unclear.

Purpose of the Study:

• To elucidate the molecular mechanisms behind placental "migration" in placenta previa.
• To investigate the role of specific genes, including soluble fms-like tyrosine kinase-1 (sFLT-1), in placental adaptation or degeneration.

Main Methods:

• Microarray analysis of human placentas from previa and control groups to identify differentially expressed genes in the caudal region.
• Quantitative reverse transcription PCR (qRT-PCR) to validate mRNA expression of target genes.
• Mouse model of reduced placental blood supply via unilateral uterine artery ablation to assess placental and fetal growth and gene expression.

Main Results:

• Microarray analysis revealed elevated expression of soluble fms-like tyrosine kinase-1 (sFLT-1) in the caudal part of placentas from women with placenta previa.
• In mice, reduced blood supply led to smaller placentas and fetuses, with significantly increased sFlt-1 expression in the affected placental regions.

Conclusions:

• Placental "migration" is likely a consequence of degeneration in the caudal region of the placenta.
• Soluble fms-like tyrosine kinase-1 (sFLT-1) is implicated in the degenerative process contributing to placental "migration" in placenta previa.